Factors associated with preimplantation genetic diagnosis acceptance among women concerned about hereditary breast and ovarian cancer

Genetics in Medicine

Volumn 11, Issue 10, 2009, Pages 757-765

  Vadaparampil, Susan T ^a,b   Quinn, Gwendolyn P ^a,b   Knapp, Caprice ^c   Malo, Teri L ^a   Friedman, Susan ^a,d  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d Facing Our Risk of Cancer Empowered FORCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE; AWARENESS; BIVARIATE ANALYSIS; BREAST CANCER; CANCER RISK; CHILD; CONTROLLED STUDY; DEMOGRAPHY; FAMILIAL CANCER; FEMALE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OVARY CANCER; PRENATAL DIAGNOSIS;

AWARENESS; BREAST NEOPLASMS; CAUSALITY; CROSS-SECTIONAL STUDIES; DATA COLLECTION; FEMALE; GENETIC COUNSELING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; ODDS RATIO; OVARIAN NEOPLASMS; PATIENT ACCEPTANCE OF HEALTH CARE; PREIMPLANTATION DIAGNOSIS;

EID: 70350225985     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181b3f451     Document Type: Article

References (31)

1. Carter RF. BRCA1, BRCA2 and breast cancer: a concise clinical review. Clin Invest Med 2001:24:147-157.
2. Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994:266:66-71. (Pubitemid 24345325)
3. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-792.
4. Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 2002;94:1365-1372.
5. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 2003;302:643-646.
6. Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 2008;7:179-186.
7. Friedman LC, Kramer RM. Reproductive issues for women with BRCA mutations. J Natl Cancer Inst Monogr 2005;(34):83-86.
8. Smith KR, Ellington L, Chan AY, Croyle RT, Botkin JR. Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 2004;13:733-740.
9. Fortuny D, Balmana J, Grana B, et al. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multi-centre Spanish cohort. Hum Reprod 2009;24:1000-1006.
10. Quinn G, Vadaparampil S, Wilson C, et al. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril 2009;91:2361-2368.
11. Cunniff C. Prenatal screening and diagnosis for pediatricians. Pediatrics 2004;114:889-894.
12. Rappaport VJ. Prenatal diagnosis and genetic screening-integration into prenatal care. Obstet Gynecol Clin North Am 2008;35:435-458.
13. Baruch S, Kaufman D, Hudson KL. Genetic testing of embryos: practices and perspectives of US in vitro fertilization clinics. Fertil Steril 2008;89:1053-1058.
14. Ogilvie CM, Braude PR, Scriven PN. Preimplantation genetic diagnosis-an overview. J Histochem Cytochem 2005;53:255-260.
15. Jasper MJ, Liebelt J, Hussey ND. Preimplantation genetic diagnosis for BRCA1 exon 13 duplication mutation using linked polymorphic markers resulting in a live birth. Prenat Diagn 2008;28:292-298.
16. Sagi M, Weinberg N, Eilat A, et al. Preimplantation genetic diagnosis for BRCA1/2-a novel clinical experience. Prenat Diagn 2009;29:508-513.
17. Offit K, Kohut K, Clagett B, et al. Cancer genetic testing and assisted reproduction. J Clin Oncol 2006;24:4775-4782.
18. Menon U, Harper J, Sharma A, et al. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 2007;22:1573-1577.
19. Hudson KL. Preimplantation genetic diagnosis: public policy and public attitudes. Fertil Steril 2006;85:1638-1645.
20. Queller J. Pretty is what changes. New York: Spiegel and Grau, 2008.
21. Paek B, Goldberg JD, Albanese CT. Prenatal diagnosis. World J Surg 2003; 27:27-37.
22. Niermeijer MF, de Wert G, Dondorp W. Preimplantation genetic diagnosis for cancer. Lancet Oncol 2006;7:794-795.
23. Testart J, Sele B. Towards an efficient medical eugenics: is the desirable always the feasible? Hum Reprod 1995;10:3086-3090.
24. Cameron C, Williamson R. Is there an ethical difference between preimplan-tation genetic diagnosis and abortion? J Med Ethics 2003;29:90-92.
25. Ahmed S, Hewison J, Green JM, Cuckle HS, Hirst J, Thornton JG. Decisions about testing and termination of pregnancy for different fetal conditions: a qualitative study of European White and Pakistani mothers of affected children. J Genet Couns 2008;17:560-572.
26. Jaber L, Dolfin T, Shohat T, Halpern GJ, Reish O, Fejgin M. Prenatal diagnosis for detecting congenital malformations: acceptance among Israeli Arab women. Isr Med Assoc J 2000;2:346-350.
27. Sheiner E, Shoham-Vardi I, Weitzman D, Gohar J, Carmi R. Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur J Obstet Gynecol Reprod Biol 1998;76:141-146.
28. Shohat M, Frimer H, Shohat-Levy V, et al. Prenatal diagnosis of Down syndrome: ten year experience in the Israeli population. Am J Med Genet A 2003;122A:215-222.
29. Mayen-Molina DG, Hernandez-Gonzalez C, Grether-Gonzalez P. [Attitude to and acceptance of prenatal cytogenetic diagnosis by pregnant women]. Gi-necol Obstet Mex 1997;65:107-110.
30. Press N, Browner CH. Characteristics of women who refuse an offer of prenatal diagnosis: data from the California maternal serum alpha fetoprotein blood test experience. Am J Med Genet 1998;78:433-445.
31. Geransar R, Einsiedel E. Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genet Test 2008;12:13-23.